Amber Enterprises India Limited (AMBER)
Investor Presentation
Investor Presentation - Q2FY27
- Consolidated revenue 2,627 Cr +60% y-y; Operating EBITDA 127 Cr +30% y-y; Adjusted PAT (57) Cr vs (32) Cr loss y-y
- Consumer Durables division revenue +41% Q2 y-y; margins impacted by commodity inflation and ramp-up costs
- Electronics division revenue +94% Q2 y-y; Operating EBITDA +195% y-y
- Railways & Defence division revenue +15% Q2 y-y; FY27 revenue growth expected 15-20%, margins to normalize in FY28
- New mobile manufacturing collaboration with Oppo; trial production Q4FY27, commercial Q1FY28
- Capex and facility expansions ongoing in PCB and railway subsystems divisions
- Consolidated H1FY27 revenue 6,515 Cr +28% y-y; Operating EBITDA 464 Cr +29% y-y; Adjusted PAT 69 Cr vs 74 Cr y-y
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AMBER — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AMBER to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Amber Enterprises India Limited
Important.
The summary above is generated automatically from Amber Enterprises India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.